In Boston the virus was introduced, perhaps by a single individual, to an international professional conference held by the biotechnology company Biogen with about 175 attendees, more than 99 of whom would end up testing positive.56 The transmission chains ignited by this event would be implicated in up to 300,000 downstream infections, according to one estimate published in the journal Science.
